Tapewire

Nasdaq · USD

RGEN

REPLIGEN CORP

Export transactions ↓
Tapewire entity
486
SEC CIK
0000730272
Parsed reports
388

Last 12 months

Inside the activity.

0 purchase rows · 25 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 2025014
Dec 202501
Jan 202600
Feb 202600
Mar 202600
Apr 202601
May 202600
Jun 202601
Jul 202601
Aug 202601
Sep 202604
Oct 202602

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
September 08, 2022 Filed Sep 9, 2022 20:14 UTC
Hunt AnthonyDirector · Chief Executive Officer
SaleCommon Stock 824 $220.08 $181,345.92
Disclosure

SEC source: 0000899243-22-030727 · doc4.xml · nonDerivative · entry 2

Hunt Anthony · CIK 0001606030 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 203,843

F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on December 14, 2021.

F2 · price: $220.08 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $219.42 to $220.39, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
September 08, 2022 Filed Sep 9, 2022 20:14 UTC
Hunt AnthonyDirector · Chief Executive Officer
Exercise / conversionCommon Stock 10,000 $33.87 $338,700.00
Disclosure

SEC source: 0000899243-22-030727 · doc4.xml · nonDerivative · entry 1

Hunt Anthony · CIK 0001606030 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 204,667

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 16, 2022 Filed Aug 17, 2022 20:41 UTC
Snodgres JonChief Financial Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 970 $0.00 Strike: $215.58 $0.00
Disclosure

SEC source: 0000899243-22-028997 · doc4.xml · derivative · entry 6

Snodgres Jon · CIK 0001613498 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,940

Underlying: Common Stock · 970 shares

Expires 2031-02-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Shares vest and become exercisable as follows: 970 shares on 2/24/2023 and 970 shares on 2/24/2024.

Read SEC document
August 16, 2022 Filed Aug 17, 2022 20:41 UTC
Snodgres JonChief Financial Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 3,047 $0.00 Strike: $86.10 $0.00
Disclosure

SEC source: 0000899243-22-028997 · doc4.xml · derivative · entry 5

Snodgres Jon · CIK 0001613498 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,524

Underlying: Common Stock · 3,047 shares

Expires 2030-02-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: 1,524 shares vest and become exercisable on 2/27/2023.

Read SEC document
August 16, 2022 Filed Aug 17, 2022 20:41 UTC
Snodgres JonChief Financial Officer
SaleCommon Stock 2,400 $253.16 $607,584.00
Disclosure

SEC source: 0000899243-22-028997 · doc4.xml · nonDerivative · entry 4

Snodgres Jon · CIK 0001613498 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,506

Read SEC document
August 16, 2022 Filed Aug 17, 2022 20:41 UTC
Snodgres JonChief Financial Officer
SaleCommon Stock 4,298 $252.70 $1,086,104.60
Disclosure

SEC source: 0000899243-22-028997 · doc4.xml · nonDerivative · entry 3

Snodgres Jon · CIK 0001613498 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,906

F1 · price: $252.70 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $252.16 to $253.11, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
August 16, 2022 Filed Aug 17, 2022 20:41 UTC
Snodgres JonChief Financial Officer
Exercise / conversionCommon Stock 970 $215.58 $209,112.60
Disclosure

SEC source: 0000899243-22-028997 · doc4.xml · nonDerivative · entry 2

Snodgres Jon · CIK 0001613498 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,204

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 16, 2022 Filed Aug 17, 2022 20:41 UTC
Snodgres JonChief Financial Officer
Exercise / conversionCommon Stock 3,047 $86.10 $262,346.70
Disclosure

SEC source: 0000899243-22-028997 · doc4.xml · nonDerivative · entry 1

Snodgres Jon · CIK 0001613498 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,234

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 11, 2022 Filed Aug 12, 2022 20:49 UTC
KURIYEL RALFSenior VP, R&D
Exercise / conversionStock Option (Right to Buy) · Derivative 646 $0.00 Strike: $86.10 $0.00
Disclosure

SEC source: 0000899243-22-028506 · doc4.xml · derivative · entry 8

KURIYEL RALF · CIK 0001733143 · Senior VP, R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 400

Underlying: Common Stock · 646 shares

Expires 2027-02-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: 1,046 shares vest and become exercisable on 2/27/2023.

Read SEC document
August 11, 2022 Filed Aug 12, 2022 20:49 UTC
KURIYEL RALFSenior VP, R&D
Exercise / conversionStock Option (Right to Buy) · Derivative 1,354 $0.00 Strike: $59.52 $0.00
Disclosure

SEC source: 0000899243-22-028506 · doc4.xml · derivative · entry 7

KURIYEL RALF · CIK 0001733143 · Senior VP, R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,354 shares

Expires 2029-02-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: This option is fully vested and exercisable.

Read SEC document
August 11, 2022 Filed Aug 12, 2022 20:49 UTC
KURIYEL RALFSenior VP, R&D
Exercise / conversionStock Option (Right to Buy) · Derivative 2,000 $0.00 Strike: $33.05 $0.00
Disclosure

SEC source: 0000899243-22-028506 · doc4.xml · derivative · entry 6

KURIYEL RALF · CIK 0001733143 · Senior VP, R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,000 shares

Expires 2026-12-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: This option is fully vested and exercisable.

Read SEC document
August 11, 2022 Filed Aug 12, 2022 20:49 UTC
KURIYEL RALFSenior VP, R&D
SaleCommon Stock 4,040 $254.14 $1,026,725.60
Disclosure

SEC source: 0000899243-22-028506 · doc4.xml · nonDerivative · entry 5

KURIYEL RALF · CIK 0001733143 · Senior VP, R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,270

F1 · price: $254.14 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $254.10 to $254.82, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
August 11, 2022 Filed Aug 12, 2022 20:49 UTC
KURIYEL RALFSenior VP, R&D
SaleCommon Stock 800 $255.20 $204,160.00
Disclosure

SEC source: 0000899243-22-028506 · doc4.xml · nonDerivative · entry 4

KURIYEL RALF · CIK 0001733143 · Senior VP, R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,310

Read SEC document
August 11, 2022 Filed Aug 12, 2022 20:49 UTC
KURIYEL RALFSenior VP, R&D
Exercise / conversionCommon Stock 646 $86.10 $55,620.60
Disclosure

SEC source: 0000899243-22-028506 · doc4.xml · nonDerivative · entry 3

KURIYEL RALF · CIK 0001733143 · Senior VP, R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,110

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 11, 2022 Filed Aug 12, 2022 20:49 UTC
KURIYEL RALFSenior VP, R&D
Exercise / conversionCommon Stock 1,354 $59.52 $80,590.08
Disclosure

SEC source: 0000899243-22-028506 · doc4.xml · nonDerivative · entry 2

KURIYEL RALF · CIK 0001733143 · Senior VP, R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,464

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 11, 2022 Filed Aug 12, 2022 20:49 UTC
KURIYEL RALFSenior VP, R&D
Exercise / conversionCommon Stock 2,000 $33.05 $66,100.00
Disclosure

SEC source: 0000899243-22-028506 · doc4.xml · nonDerivative · entry 1

KURIYEL RALF · CIK 0001733143 · Senior VP, R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,110

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 04, 2022 Filed Aug 5, 2022 20:29 UTC
Gebski ChristineSee Remarks
SaleCommon Stock 3,357 $243.01 $815,784.57
Disclosure

SEC source: 0000899243-22-027833 · doc4.xml · nonDerivative · entry 1

Gebski Christine · CIK 0001849585 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,735

F1 · price: $243.01 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $242.98 to $243.11, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
August 03, 2022 Filed Aug 4, 2022 20:32 UTC
Bylund JamesChief Operating Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 2,000 $0.00 Strike: $94.33 $0.00
Disclosure

SEC source: 0000899243-22-027710 · doc4.xml · derivative · entry 3

Bylund James · CIK 0001849642 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,000

Underlying: Common Stock · 2,000 shares

Expires 2030-04-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: 4,000 of the shares underlying the option have vested. The remaining shares vest as follows: 2,000 shares on April 1, 2023, April 1, 2024 and April 1, 2025.

Read SEC document
August 03, 2022 Filed Aug 4, 2022 20:32 UTC
Bylund JamesChief Operating Officer
SaleCommon Stock 2,000 $240.40 $480,800.00
Disclosure

SEC source: 0000899243-22-027710 · doc4.xml · nonDerivative · entry 2

Bylund James · CIK 0001849642 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,733

F1 · price: $240.40 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $240.36 to $240.55, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
August 03, 2022 Filed Aug 4, 2022 20:32 UTC
Bylund JamesChief Operating Officer
Exercise / conversionCommon Stock 2,000 $94.33 $188,660.00
Disclosure

SEC source: 0000899243-22-027710 · doc4.xml · nonDerivative · entry 1

Bylund James · CIK 0001849642 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,733

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 01, 2022 Filed Aug 2, 2022 21:26 UTC
Snodgres JonChief Financial Officer
SaleCommon Stock 2,000 $220.00 $440,000.00
Disclosure

SEC source: 0000899243-22-027415 · doc4.xml · nonDerivative · entry 1

Snodgres Jon · CIK 0001613498 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,187

F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on March 9, 2022.

Read SEC document
July 21, 2022 Filed Jul 22, 2022 20:25 UTC
Hunt AnthonyDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 15,154 $0.00 Strike: $32.40 $0.00
Disclosure

SEC source: 0000899243-22-026581 · doc4.xml · derivative · entry 5

Hunt Anthony · CIK 0001606030 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 15,154 shares

Expires 2027-02-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: This option is fully vested and exercisable.

Read SEC document
July 21, 2022 Filed Jul 22, 2022 20:25 UTC
Hunt AnthonyDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 5,000 $0.00 Strike: $33.87 $0.00
Disclosure

SEC source: 0000899243-22-026581 · doc4.xml · derivative · entry 4

Hunt Anthony · CIK 0001606030 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,246

Underlying: Common Stock · 5,000 shares

Expires 2028-02-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: This option is fully vested and exercisable.

Read SEC document
July 21, 2022 Filed Jul 22, 2022 20:25 UTC
Hunt AnthonyDirector · Chief Executive Officer
SaleCommon Stock 24,802 $200.00 $4,960,400.00
Disclosure

SEC source: 0000899243-22-026581 · doc4.xml · nonDerivative · entry 3

Hunt Anthony · CIK 0001606030 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 194,667

F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on December 14, 2021.

Read SEC document
July 21, 2022 Filed Jul 22, 2022 20:25 UTC
Hunt AnthonyDirector · Chief Executive Officer
Exercise / conversionCommon Stock 15,154 $32.40 $490,989.60
Disclosure

SEC source: 0000899243-22-026581 · doc4.xml · nonDerivative · entry 2

Hunt Anthony · CIK 0001606030 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 219,469

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 21, 2022 Filed Jul 22, 2022 20:25 UTC
Hunt AnthonyDirector · Chief Executive Officer
Exercise / conversionCommon Stock 5,000 $33.87 $169,350.00
Disclosure

SEC source: 0000899243-22-026581 · doc4.xml · nonDerivative · entry 1

Hunt Anthony · CIK 0001606030 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 204,315

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 26, 2022 Filed Jun 1, 2022 00:25 UTC
Mhatre RohinDirector
GrantStock Option (Right to Buy) · Derivative 2,920 $0.00 Strike: $159.17 $0.00
Disclosure

SEC source: 0000899243-22-020284 · doc4.xml · derivative · entry 2

Mhatre Rohin · CIK 0001798735 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,920

Underlying: Common Stock · 2,920 shares

Expires 2032-05-26

F2 · derivative.exercise_date: Award vests in full on the earlier of May 26, 2023, one year from grant date, or on the date of the next annual meeting of the Company's shareholders, which has not yet been determined.

Read SEC document
May 26, 2022 Filed Jun 1, 2022 00:25 UTC
Mhatre RohinDirector
GrantCommon Stock 1,202 $0.00 $0.00
Disclosure

SEC source: 0000899243-22-020284 · doc4.xml · nonDerivative · entry 1

Mhatre Rohin · CIK 0001798735 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,659

F1 · shares: Mr. Mhatre was awarded 1,202 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on the earlier of May 26, 2023, one year from the grant date, or the date of the next annual meeting of the Company's shareholders, which has not yet been determined. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.

Read SEC document
May 26, 2022 Filed Jun 1, 2022 00:23 UTC GrantStock Option (Right to Buy) · Derivative 2,498 $0.00 Strike: $159.17 $0.00
Disclosure

SEC source: 0000899243-22-020283 · doc4.xml · derivative · entry 3

Konstantinov Konstantin · CIK 0001774649 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,498

Underlying: Common Stock · 2,498 shares

Expires 2032-05-26

F3 · derivative.exercise_date: The shares vest in equal annual instalments over a three-year period with each such vesting date occurring on the earlier of the anniversary of the grant date or the date of the annual meeting of the Company's shareholders of the applicable year of such three-year period.

Read SEC document
May 26, 2022 Filed Jun 1, 2022 00:23 UTC GrantStock Option (Right to Buy) · Derivative 1,298 $0.00 Strike: $159.17 $0.00
Disclosure

SEC source: 0000899243-22-020283 · doc4.xml · derivative · entry 2

Konstantinov Konstantin · CIK 0001774649 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,298

Underlying: Common Stock · 1,298 shares

Expires 2032-05-26

F2 · derivative.exercise_date: Award vests in full on May 26, 2023, one year from grant date.

Read SEC document
May 26, 2022 Filed Jun 1, 2022 00:23 UTC GrantCommon Stock 534 $0.00 $0.00
Disclosure

SEC source: 0000899243-22-020283 · doc4.xml · nonDerivative · entry 1

Konstantinov Konstantin · CIK 0001774649 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 534

F1 · shares: Mr. Konstantinov was awarded 534 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on May 26, 2023, one year from the grant date. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.

Read SEC document
May 26, 2022 Filed Jun 1, 2022 00:21 UTC GrantStock Option (Right to Buy) · Derivative 1,565 $0.00 Strike: $159.17 $0.00
Disclosure

SEC source: 0000899243-22-020280 · doc4.xml · derivative · entry 2

DAWES KAREN A · CIK 0001261506 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,565

Underlying: Common Stock · 1,565 shares

Expires 2032-05-26

F2 · derivative.exercise_date: Award vests in full on the earlier of May 26, 2023, one year from grant date, or on the date of the next annual meeting of the Company's shareholders, which has not yet been determined.

Read SEC document
May 26, 2022 Filed Jun 1, 2022 00:21 UTC GrantCommon Stock 644 $0.00 $0.00
Disclosure

SEC source: 0000899243-22-020280 · doc4.xml · nonDerivative · entry 1

DAWES KAREN A · CIK 0001261506 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,176

F1 · shares: Ms. Dawes was awarded 644 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on the earlier of May 26, 2023, one year from the grant date, or the date of the next annual meeting of the Company's shareholders, which has not yet been determined. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.

Read SEC document
May 26, 2022 Filed Jun 1, 2022 00:20 UTC GrantStock Option (Right to Buy) · Derivative 1,298 $0.00 Strike: $159.17 $0.00
Disclosure

SEC source: 0000899243-22-020279 · doc4.xml · derivative · entry 2

BARTHELEMY NICOLAS · CIK 0001283576 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,298

Underlying: Common Stock · 1,298 shares

Expires 2032-05-26

F2 · derivative.exercise_date: Award vests in full on the earlier of May 26, 2023, one year from grant date, or on the date of the next annual meeting of the Company's shareholders, which has not yet been determined.

Read SEC document
May 26, 2022 Filed Jun 1, 2022 00:20 UTC GrantCommon Stock 534 $0.00 $0.00
Disclosure

SEC source: 0000899243-22-020279 · doc4.xml · nonDerivative · entry 1

BARTHELEMY NICOLAS · CIK 0001283576 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,081

F1 · shares: Mr. Barthelemy was awarded 534 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on the earlier of May 26, 2023, one year from the grant date, or the date of the next annual meeting of the Company's shareholders, which has not yet been determined. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.

Read SEC document
May 26, 2022 Filed Jun 1, 2022 00:17 UTC
MUIR GLENN PDirector
GrantStock Option (Right to Buy) · Derivative 1,298 $0.00 Strike: $159.17 $0.00
Disclosure

SEC source: 0000899243-22-020276 · doc4.xml · derivative · entry 2

MUIR GLENN P · CIK 0001181190 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,298

Underlying: Common Stock · 1,298 shares

Expires 2032-05-26

F2 · derivative.exercise_date: Award vests in full on the earlier of May 26, 2023, one year from grant date, or on the date of the next annual meeting of the Company's shareholders, which has not yet been determined.

Read SEC document
May 26, 2022 Filed Jun 1, 2022 00:17 UTC
MUIR GLENN PDirector
GrantCommon Stock 534 $0.00 $0.00
Disclosure

SEC source: 0000899243-22-020276 · doc4.xml · nonDerivative · entry 1

MUIR GLENN P · CIK 0001181190 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,896

F1 · shares: Mr. Muir was awarded 534 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on the earlier of May 26, 2023, one year from the grant date, or the date of the next annual meeting of the Company's shareholders, which has not yet been determined. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.

Read SEC document
May 26, 2022 Filed Jun 1, 2022 00:15 UTC GrantStock Option (Right to Buy) · Derivative 2,488 $0.00 Strike: $159.17 $0.00
Disclosure

SEC source: 0000899243-22-020272 · doc4.xml · derivative · entry 2

EGLINTON MANNER CARRIE · CIK 0001696776 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,488

Underlying: Common Stock · 2,488 shares

Expires 2032-05-26

F2 · derivative.exercise_date: Award vests in full on the earlier of May 26, 2023, one year from grant date, or on the date of the next annual meeting of the Company's shareholders, which has not yet been determined.

Read SEC document
May 26, 2022 Filed Jun 1, 2022 00:15 UTC GrantCommon Stock 1,024 $0.00 $0.00
Disclosure

SEC source: 0000899243-22-020272 · doc4.xml · nonDerivative · entry 1

EGLINTON MANNER CARRIE · CIK 0001696776 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,481

F1 · shares: Ms. Eglinton Manner was awarded 1,024 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on the earlier of May 26, 2023, one year from the grant date, or the date of the next annual meeting of the Company's shareholders, which has not yet been determined. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.

Read SEC document
May 25, 2022 Filed May 26, 2022 21:17 UTC SaleCommon Stock 742 $152.84 $113,407.28
Disclosure

SEC source: 0000899243-22-019772 · doc4.xml · nonDerivative · entry 5

DAWES KAREN A · CIK 0001261506 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,532

F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on June 8, 2021.

F6 · price: $152.84 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $152.69 to $153.03, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
May 25, 2022 Filed May 26, 2022 21:17 UTC SaleCommon Stock 1,875 $152.14 $285,262.50
Disclosure

SEC source: 0000899243-22-019772 · doc4.xml · nonDerivative · entry 4

DAWES KAREN A · CIK 0001261506 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,274

F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on June 8, 2021.

F5 · price: $152.14 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $151.63 to $152.61, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
May 25, 2022 Filed May 26, 2022 21:17 UTC SaleCommon Stock 1,845 $151.14 $278,853.30
Disclosure

SEC source: 0000899243-22-019772 · doc4.xml · nonDerivative · entry 3

DAWES KAREN A · CIK 0001261506 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 79,149

F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on June 8, 2021.

F4 · price: $151.14 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $150.63 to $151.55, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
May 25, 2022 Filed May 26, 2022 21:17 UTC SaleCommon Stock 7,677 $150.19 $1,153,008.63
Disclosure

SEC source: 0000899243-22-019772 · doc4.xml · nonDerivative · entry 2

DAWES KAREN A · CIK 0001261506 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,994

F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on June 8, 2021.

F3 · price: $150.19 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $149.62 to $150.61, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
May 25, 2022 Filed May 26, 2022 21:17 UTC SaleCommon Stock 2,576 $149.18 $384,287.68
Disclosure

SEC source: 0000899243-22-019772 · doc4.xml · nonDerivative · entry 1

DAWES KAREN A · CIK 0001261506 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 88,671

F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on June 8, 2021.

F2 · price: $149.18 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $148.61 to $149.58, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
May 13, 2022 Filed May 17, 2022 21:00 UTC
KURIYEL RALFSenior VP, R&D
Tax withholdingCommon Stock 712 $150.40 $107,084.80
Disclosure

SEC source: 0000899243-22-018418 · doc4.xml · nonDerivative · entry 1

KURIYEL RALF · CIK 0001733143 · Senior VP, R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,110

F1 · shares: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units.

Read SEC document
May 13, 2022 Filed May 17, 2022 20:59 UTC
Snodgres JonChief Financial Officer
Tax withholdingCommon Stock 712 $150.40 $107,084.80
Disclosure

SEC source: 0000899243-22-018416 · doc4.xml · nonDerivative · entry 1

Snodgres Jon · CIK 0001613498 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,187

F1 · shares: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units.

Read SEC document
May 13, 2022 Filed May 17, 2022 20:59 UTC
Gebski ChristineSee Remarks
Tax withholdingCommon Stock 335 $150.40 $50,384.00
Disclosure

SEC source: 0000899243-22-018417 · doc4.xml · nonDerivative · entry 1

Gebski Christine · CIK 0001849585 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,092

F1 · shares: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units.

Read SEC document
April 01, 2022 Filed Apr 4, 2022 21:57 UTC
Bylund JamesChief Operating Officer
Tax withholdingCommon Stock 335 $188.02 $62,986.70
Disclosure

SEC source: 0000899243-22-013421 · doc4.xml · nonDerivative · entry 1

Bylund James · CIK 0001849642 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,733

F1 · shares: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units.

Read SEC document
March 16, 2022 Filed Dec 15, 2022 11:55 UTC PurchaseCommon Stock 625 $175.02 $109,387.50
Disclosure

SEC source: 0000899243-22-038565 · doc4.xml · nonDerivative · entry 1

EGLINTON MANNER CARRIE · CIK 0001696776 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,106

Read SEC document
March 08, 2022 Filed Mar 10, 2022 01:02 UTC
Snodgres JonChief Financial Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 1,214 $0.00 Strike: $59.52 $0.00
Disclosure

SEC source: 0000899243-22-010327 · doc4.xml · derivative · entry 4

Snodgres Jon · CIK 0001613498 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,574

Underlying: Common Stock · 1,214 shares

Expires 2029-02-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: This option is currently exercisable.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.